These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23391114)

  • 1. Management of well-differentiated gastrointestinal neuroendocrine tumors metastatic to the liver.
    Wang SC; Fidelman N; Nakakura EK
    Semin Oncol; 2013 Feb; 40(1):69-74. PubMed ID: 23391114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors.
    Kennedy AS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic neuroendocrine hepatic tumors: resection improves survival.
    Musunuru S; Chen H; Rajpal S; Stephani N; McDermott JC; Holen K; Rikkers LF; Weber SM
    Arch Surg; 2006 Oct; 141(10):1000-4; discussion 1005. PubMed ID: 17043278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease.
    Liu DM; Kennedy A; Turner D; Rose SC; Kee ST; Whiting S; Murthy R; Nutting C; Heran M; Lewandowski R; Knight J; Gulec S; Salem R
    Am J Clin Oncol; 2009 Apr; 32(2):200-15. PubMed ID: 19346815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interventional therapy of neuroendokrine tumors of the gastrointestinal tract].
    Kettenbach J; Müller SL; Schindl M
    Wien Klin Wochenschr; 2003; 115 Suppl 2():56-64. PubMed ID: 15518148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors.
    Ho AS; Picus J; Darcy MD; Tan B; Gould JE; Pilgram TK; Brown DB
    AJR Am J Roentgenol; 2007 May; 188(5):1201-7. PubMed ID: 17449759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.
    Gaur SK; Friese JL; Sadow CA; Ayyagari R; Binkert CA; Schenker MP; Kulke M; Baum R
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):566-72. PubMed ID: 21431978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation of neuroendocrine hepatic metastasis.
    Gamblin TC; Christians K; Pappas SG
    Surg Oncol Clin N Am; 2011 Apr; 20(2):273-9, vii-viii. PubMed ID: 21377583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodality treatment of neuroendocrine liver metastases.
    Karabulut K; Akyildiz HY; Lance C; Aucejo F; McLennan G; Agcaoglu O; Siperstein A; Berber E
    Surgery; 2011 Aug; 150(2):316-25. PubMed ID: 21801968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-directed therapies in patients with advanced neuroendocrine tumors.
    Jones NB; Shah MH; Bloomston M
    J Natl Compr Canc Netw; 2012 Jun; 10(6):765-74. PubMed ID: 22679118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ; Davidson BR
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for gastro-enteropancreatic endocrine tumours.
    O'Toole D; Hentic O; Corcos O; Ruszniewski P
    Neuroendocrinology; 2004; 80 Suppl 1():79-84. PubMed ID: 15477723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases.
    Ljungberg M; Westberg G; Vikhoff-Baaz B; Starck G; Wängberg B; Ekholm S; Ahlman H; Forssell-Aronsson E
    Acta Radiol; 2012 Dec; 53(10):1118-26. PubMed ID: 23051638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic management of patients with gastroenteropancreatic neuroendocrine tumours.
    Khan MS; Caplin ME
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S53-74. PubMed ID: 22005115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of gastrointestinal neuroendocrine tumors.
    Modlin IM; Basson MD; Mani S
    Gastroenterologist; 1993 Mar; 1(1):59-70. PubMed ID: 8049881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.